Top Cited Articles

Acceptance Rate

13%

Time to first decision

14 days*

Impact Factor

9.25

Impact Factor rank (JCR)

7/64

Citescore

13.5

2020 total Altmetric mentions

9,718

Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
Mandal, Swapna; Barnett, Joseph; Brill, Simon E. et al
10.1136/thoraxjnl-2020-215818

Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort
Arnold, David T.; Hamilton, Fergus W.; Milne, Alice. et al
10.1136/thoraxjnl-2020-216086

SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
Shields, Adrian; Faustini, Sian E.; Perez-Toledo, Marisol. et al
10.1136/thoraxjnl-2020-215414

COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms
Loo, Joan; Spittle, Daniella A.; Newnham, Michael
10.1136/thoraxjnl-2020-216243

Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection
Ra, Sang Hyun; Lim, Joon Seo; Kim, Gwang-un. et al
10.1136/thoraxjnl-2020-215042

High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection
Vianello, Andrea; Arcaro, Giovanna; Molena, Beatrice. et al
10.1136/thoraxjnl-2020-214993

Respiratory follow-up of patients with COVID-19 pneumonia
George, Peter M.; Barratt, Shaney L.; Condliffe, Robin. et al
10.1136/thoraxjnl-2020-215314

COVID-19: in the footsteps of Ernest Shackleton
Ing, Alvin J.; Cocks, Christine; Green, Jeffery Peter
10.1136/thoraxjnl-2020-215091

Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19)
Ryan, Daniel J.; Toomey, Sinead; Madden, Stephen F. et al
10.1136/thoraxjnl-2020-215705

Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length
McGroder, Claire F.; Zhang, David; Choudhury, Mohammad A. et al
10.1136/thoraxjnl-2021-217031

Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study
Stavem, Knut; Ghanima, Waleed; Olsen, Magnus Kringstad et al
10.1136/thoraxjnl-2020-216377

Return to work after critical illness: a systematic review and meta-analysis
Kamdar, Biren B.; Suri, Rajat; Suchyta, Mary R. et al
10.1136/thoraxjnl-2019-213803

Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits
Mathioudakis, Alexander G.; Janssens, Wim; Sivapalan, Pradeesh. et al
10.1136/thoraxjnl-2019-214484

Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study
Meghji, Jamilah; Lesosky, Maia; Joekes, Elizabeth. et al
10.1136/thoraxjnl-2019-213808

Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19
Khan, Fasihul A.; Stewart, Iain; Fabbri, Laura. et al
10.1136/thoraxjnl-2020-215266

Zinc supplementation ameliorates lung injury by reducing neutrophil recruitment and activity
Wessels, Inga; Pupke, Johanna Theresa; von Trotha, Klaus-Thilo. et al
10.1136/thoraxjnl-2019-213357

Awake prone positioning in COVID-19
Koeckerling, David; Barker, Joseph; Mudalige, Nadeesha L. et al
10.1136/thoraxjnl-2020-215133

Association between particulate matter air pollution and lung cancer
Zhang, Zhenyu; Zhu, Dawei; Cui, Bin. et al
10.1136/thoraxjnl-2019-213722

Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score
Berenguer, Juan; Borobia, Alberto M.; Ryan, Pablo. et al
10.1136/thoraxjnl-2020-216001

Body mass index and weight change are associated with adult lung function trajectories: the prospective ECRHS study
Peralta, Gabriela P.; Marcon, Alessandro; Carsin, Anne-Elie. et al
10.1136/thoraxjnl-2019-213880